Search
for
Sort by
Research 61–90 of 1000+
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- Alopecia Totalis/Universalis
- Alopecia Areata: Current Treatments and New Directions
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Alopecia universalis during treatment with leflunomide and adalimumab - Case report
- Alopecia areata in a rhesus monkey (Macaca mulatta)
- Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- Alopecia areata after denosumab treatment for osteoporosis
- Alopecia universalis unresponsive to treatment with tofacinitib: report of a case with a brief review of the literature
- Alopecia areata secondary to the use of leflunomide in patients with rheumatoid arthritis: a case report and literature review
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
- Alopecia Areata and malignancies: uncertainties clarified by a large-scale population-based study
- Treatments for alopecia areata: a network meta-analysis
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- Inverse correlation between vitamin D and CRP levels in alopecia areata: A pilot study
- Alopecia Areata: Current Review
- ALOPECIA AREATA IN INFANTS: IS IT UNCOMMON?
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- Emotional burden and current management practices in pediatric alopecia areata: An online survey among physicians
- Alopecia Universalis after COVID-19 Vaccination: Case Report and Literature Review
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Systemic treatments for alopecia areata: A systematic review
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Medium-dose prednisolone pulse therapy in alopecia areata
- Extensive alopecia areata: Not necessarily recalcitrant to therapy!
- Experience with oral tofacitinib in severe alopecia areata with different clinical responses
- Prognostic Factors in Mexican Patients with Patchy and Other Types of Alopecia Areata